SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Prime Medicine Q3'26 Results Preview

Prime Medicine is scheduled to report Q3'26 results on October 30. Revenue and EPS estimates were provided, but their numeric values are omitted here.

PRME

Prime Medicine, Inc. (PRME) is scheduled to report Q3'26 results on October 30; the announcement time has not been specified. The results are expected to be released at 8:00 AM ET (12:00 PM UTC). For Q3'26, estimated revenue is 1.33 million USD, while EPS (earnings per share) is anticipated at (0.24) USD.